Filling of a water-free void explains the allosteric regulation of the β1-adrenergic receptor by cholesterol
Recent high-pressure NMR results indicate that the preactive conformation of the β 1 -adrenergic receptor (β 1 AR) harbours completely empty cavities of ~100 Å 3 volume, which disappear in the active conformation of the receptor. Here we have localized these cavities using X-ray crystallography of x...
Gespeichert in:
Veröffentlicht in: | Nature chemistry 2022-10, Vol.14 (10), p.1133-1141 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recent high-pressure NMR results indicate that the preactive conformation of the β
1
-adrenergic receptor (β
1
AR) harbours completely empty cavities of ~100 Å
3
volume, which disappear in the active conformation of the receptor. Here we have localized these cavities using X-ray crystallography of xenon-derivatized β
1
AR crystals. One of the cavities is in direct contact with the cholesterol-binding pocket. Solution NMR shows that addition of the cholesterol analogue cholesteryl hemisuccinate impedes the formation of the active conformation of detergent-solubilized β
1
AR by blocking conserved G protein-coupled receptor microswitches, concomitant with an affinity reduction of both isoprenaline and G protein-mimicking nanobody Nb80 for β
1
AR detected by isothermal titration calorimetry. This wedge-like action explains the function of cholesterol as a negative allosteric modulator of β
1
AR. A detailed understanding of G protein-coupled receptor regulation by cholesterol by filling of a dry void and the easy scouting for such voids by xenon may provide new routes for the development of allosteric drugs.
The β
1
-adrenergic receptor (β
1
AR) contains empty cavities in its preactive conformation, which disappear in the active one. Now, using X-ray crystallography of xenon-derivatized β
1
AR crystals, a cavity has been shown to be in contact with the cholesterol-binding pocket. Monitoring the binding of a cholesterol analogue in solution has explained the function of cholesterol as a negative allosteric modulator of β
1
AR. |
---|---|
ISSN: | 1755-4330 1755-4349 |
DOI: | 10.1038/s41557-022-01009-9 |